Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study.
Muta T, Masamoto Y, Yamamoto G, Kurahashi S, Kameoka Y, Ota S, Matsuki E, Ozeki K, Toyama T, Takahashi N, Kumode T, Aotsuka N, Yoshimura T, Tamura H, Omi A, Shibayama K, Watanabe A, Isobe Y, Kojima K, Takizawa J, Nagai H, Suzumiya J, Aoki S.
Muta T, et al. Among authors: ozeki k.
Int J Hematol. 2025 Feb;121(2):161-173. doi: 10.1007/s12185-024-03875-0. Epub 2024 Nov 26.
Int J Hematol. 2025.
PMID: 39586984